BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 19154107)

  • 1. Dried blood spots as a sample collection technique for the determination of pharmacokinetics in clinical studies: considerations for the validation of a quantitative bioanalytical method.
    Spooner N; Lad R; Barfield M
    Anal Chem; 2009 Feb; 81(4):1557-63. PubMed ID: 19154107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of dried plasma spots in the determination of pharmacokinetics in clinical studies: validation of a quantitative bioanalytical method.
    Barfield M; Wheller R
    Anal Chem; 2011 Jan; 83(1):118-24. PubMed ID: 21138260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dried blood spots as a sampling technique for the quantitative determination of guanfacine in clinical studies.
    Li Y; Henion J; Abbott R; Wang P
    Bioanalysis; 2011 Nov; 3(22):2501-14. PubMed ID: 22122599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of dried blood spots combined with HPLC-MS/MS for the quantification of acetaminophen in toxicokinetic studies.
    Barfield M; Spooner N; Lad R; Parry S; Fowles S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(1):32-7. PubMed ID: 18550454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perforated dried blood spot accurate microsampling: the concept and its applications in toxicokinetic sample collection.
    Li F; Ploch S; Fast D; Michael S
    J Mass Spectrom; 2012 May; 47(5):655-67. PubMed ID: 22576879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementing DBS methodology for the determination of Compound A in monkey blood: GLP method validation and investigation of the impact of blood spreading on performance.
    Fan L; Lee J; Hall J; Tolentino EJ; Wu H; El-Shourbagy T
    Bioanalysis; 2011 Jun; 3(11):1241-52. PubMed ID: 21649500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct quantitative bioanalysis of drugs in dried blood spot samples using a thin-layer chromatography mass spectrometer interface.
    Abu-Rabie P; Spooner N
    Anal Chem; 2009 Dec; 81(24):10275-84. PubMed ID: 19919036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of DBS sample collection to determine circulating drug concentrations in clinical trials: practicalities and considerations.
    Spooner N; Ramakrishnan Y; Barfield M; Dewit O; Miller S
    Bioanalysis; 2010 Aug; 2(8):1515-22. PubMed ID: 21083351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of individual quantitative methods for determination of cytochrome P450 probe substrates in human dried blood spots with HPLC-MS/MS.
    Lad R
    Bioanalysis; 2010 Nov; 2(11):1849-61. PubMed ID: 21083493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct analysis in real time coupled with dried spot sampling for bioanalysis in a drug-discovery setting.
    Crawford E; Gordon J; Wu JT; Musselman B; Liu R; Yu S
    Bioanalysis; 2011 Jun; 3(11):1217-26. PubMed ID: 21649498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dried blood spot sampling in combination with LC-MS/MS for quantitative analysis of small molecules.
    Li W; Tse FL
    Biomed Chromatogr; 2010 Jan; 24(1):49-65. PubMed ID: 20017122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of a liquid extraction based sealing surface sampling probe for mass spectrometric analysis of dried blood spots and mouse whole-body thin tissue sections.
    Van Berkel GJ; Kertesz V
    Anal Chem; 2009 Nov; 81(21):9146-52. PubMed ID: 19817477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the feasibility of using the DBS technique for metabolite radioprofiling.
    Wang L; Zeng Z; Emmons G
    Bioanalysis; 2010 Aug; 2(8):1365-71. PubMed ID: 21083337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of moxifloxacin in dried blood spots using LC-MS/MS and the impact of the hematocrit and blood volume.
    Vu DH; Koster RA; Alffenaar JW; Brouwers JR; Uges DR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 May; 879(15-16):1063-70. PubMed ID: 21459055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of dried blood spots technique for the determination of dextromethorphan and its metabolite dextrorphan in human whole blood by LC-MS/MS.
    Liang X; Li Y; Barfield M; Ji QC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Mar; 877(8-9):799-806. PubMed ID: 19237324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated system for on-line desorption of dried blood spots applied to LC/MS/MS pharmacokinetic study of flurbiprofen and its metabolite.
    Déglon J; Thomas A; Daali Y; Lauer E; Samer C; Desmeules J; Dayer P; Mangin P; Staub C
    J Pharm Biomed Anal; 2011 Jan; 54(2):359-67. PubMed ID: 20864289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of hematocrit on assay bias when using DBS samples for the quantitative bioanalysis of drugs.
    Denniff P; Spooner N
    Bioanalysis; 2010 Aug; 2(8):1385-95. PubMed ID: 21083339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of a high-sensitivity assay for zatebradine in dried blood spots of human blood at pg/ml concentrations using HILIC-MS/MS.
    Michi M; Ferrari L
    Bioanalysis; 2010 Nov; 2(11):1863-71. PubMed ID: 21083494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study to assess the effect of age of control human and animal blood on its suitability for use in quantitative bioanalytical DBS methods.
    Abu-Rabie P; Spooner N
    Bioanalysis; 2010 Aug; 2(8):1373-84. PubMed ID: 21083338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of mycophenolic acid and its phenyl glucuronide in human plasma, ultrafiltrate, blood, DBS and dried plasma spots.
    Heinig K; Bucheli F; Hartenbach R; Gajate-Perez A
    Bioanalysis; 2010 Aug; 2(8):1423-35. PubMed ID: 21083343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.